| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 14.11. | Range Impact reports Q3 results | 2 | Seeking Alpha | ||
| 14.11. | Range Impact, Inc.: Range Impact Reports 3Q 2025 Financial Results | 122 | GlobeNewswire (Europe) | Cleveland, Ohio, Nov. 14, 2025 (GLOBE NEWSWIRE) -- Range Impact, Inc. (OTCQB: RNGE) ("Range Impact" or the "Company"), a public impact investing company dedicated to acquiring, reclaiming and repurposing... ► Artikel lesen | |
| 14.11. | RANGE IMPACT, INC. - 8-K, Current Report | - | SEC Filings | ||
| RANGE IMPACT Aktie jetzt für 0€ handeln | |||||
| 14.11. | RANGE IMPACT, INC. - 10-Q, Quarterly Report | - | SEC Filings | ||
| 24.09. | Range Impact raises $550,000 | 1 | Seeking Alpha | ||
| 24.09. | Range Impact, Inc.: Range Impact Announces $550,000 Capital Raise | 1 | GlobeNewswire (USA) | ||
| 24.09. | RANGE IMPACT, INC. - 8-K, Current Report | 1 | SEC Filings | ||
| 15.08. | Range Impact GAAP EPS of -$0.01, revenue of $1.39M | 3 | Seeking Alpha | ||
| 14.08. | RANGE IMPACT, INC. - 10-Q, Quarterly Report | 1 | SEC Filings | ||
| 14.08. | Range Impact, Inc.: Range Impact Reports 2Q 2025 Financial Results | 159 | GlobeNewswire (Europe) | Cleveland, Ohio, Aug. 14, 2025 (GLOBE NEWSWIRE) -- Range Impact, Inc. (OTCQB: RNGE) ("Range Impact" or the "Company"), a public impact investing company dedicated to acquiring, reclaiming and repurposing... ► Artikel lesen | |
| 14.08. | RANGE IMPACT, INC. - 8-K, Current Report | 1 | SEC Filings | ||
| 03.07. | RANGE IMPACT, INC. - 8-K, Current Report | 2 | SEC Filings | ||
| 03.07. | Range Impact, Inc.: Range Impact Announces Expansion of Investment in its Fola Mine Complex with Acquisition of Two Mining Permits and Two Coal Leases | 200 | GlobeNewswire (Europe) | CLEVELAND, OHIO, July 02, 2025 (GLOBE NEWSWIRE) -- Range Impact, Inc. (OTCQB: RNGE) ("Range Impact" or the "Company"), a public company dedicated to acquiring, reclaiming and repurposing distressed... ► Artikel lesen | |
| 15.05. | Range Impact, Inc.: Range Impact Reports 1Q 2025 Financial Results | 134 | GlobeNewswire (Europe) | Cleveland, Ohio, May 15, 2025 (GLOBE NEWSWIRE) -- Range Impact, Inc. (OTCQB: RNGE) ("Range Impact" or the "Company"), a public impact investing company dedicated to acquiring, reclaiming and repurposing... ► Artikel lesen | |
| 02.04. | Range Impact, Inc.: Range Impact Announces Major Land Acquisition in West Virginia | 156 | GlobeNewswire (Europe) | CLEVELAND, OHIO, April 02, 2025 (GLOBE NEWSWIRE) -- Range Impact, Inc. (OTCQB: RNGE) ("Range Impact" or the "Company"), a public company dedicated to acquiring, reclaiming and repurposing distressed... ► Artikel lesen |
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| NOVO NORDISK | 41,500 | -0,16 % | Novo Nordisk Aktie: Ist die Zeit für die große Trendwende gekommen? | Spannung bei der Novo Nordisk Aktie: Der tief gefallene Aktienkurs des dänischen Pharmakonzerns arbeitet an einer potenziellen Wende nach oben, stößt aber auf massiven charttechnischen Widerstand. Nach... ► Artikel lesen | |
| AURORA CANNABIS | 4,740 | +0,74 % | AURORA CANNABIS INC stürzt ab - ich warne vor dem Desaster! | ||
| CANOPY GROWTH | 1,574 | +1,03 % | Berauschende Überlegungen: Cannabis-Aktien wie Tilray, Green Thumb oder Canopy Growth springen hoch | Gedankenspiele in den USA, die Klassifizierung von Marihuana zu ändern und die Substanz so als weniger gefährlich einzustufen, sorgen vor dem Wochenende für Euphorie an der Börse. Der Schritt könnte... ► Artikel lesen | |
| TILRAY BRANDS | 11,952 | +0,79 % | Why Tilray Stock Soared 27.5% Today | ||
| VERTEX PHARMACEUTICALS | 388,75 | +0,36 % | Vertex Presents New CASGEVY Data Highlighting Benefits In Children Ages 5-11 | CAMBRIDGE (MASSACHUSETTS) (dpa-AFX) - Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) announced new data from pivotal studies of CASGEVY (exagamglogene autotemcel), demonstrating the transformative... ► Artikel lesen | |
| TAAT GLOBAL ALTERNATIVES | 0,136 | -100,00 % | TAAT Global Alternatives Inc (2): TAAT Global CEO Saxon resigns | ||
| CRONOS GROUP | 2,740 | +1,63 % | Cronos Group Plans Strategic Europe Expansion: How to Play the Stock? | ||
| DIGICANN VENTURES | 0,004 | +600,00 % | XFRA VY3: WIEDERAUFNAHME/RESUMPTION | FOLGENDE(S) INSTRUMENT(E) WIRD/ WERDEN WIEDER IN DEN HANDEL AUFGENOMMEN MIT FOLGENDEM TRADING SCHEDULE.THE FOLLOWING INSTRUMENT(S) IS/ARE RESUMED TRADING WITH FOLLOWING TRADING SCHEDULE:INSTRUMENT NAME... ► Artikel lesen | |
| EYEPOINT | 14,225 | -1,32 % | EyePoint Pharmaceuticals, Inc.: EyePoint Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) | ||
| ORGANIGRAM GLOBAL | 1,700 | +2,41 % | OrganiGram: Umsatzsprung im vierten Quartal treibt Aktie vorbörslich an | ||
| GREEN THUMB INDUSTRIES | 8,025 | -1,05 % | Green Thumb zieht kräftig an - das ist der Grund | Die bekanntesten Cannabis-Aktien springen am Freitag kräftig an, für die laufende AKTIONÄR-Empfehlung Green Thumb geht es um mehr als 20 Prozent nach oben. Ausgelöst wurde die Bewegung durch einen Artikel... ► Artikel lesen | |
| MYDECINE INNOVATIONS GROUP | 0,116 | 0,00 % | XFRA NEW INSTRUMENTS AVAILABLE ON 22.10.2025 | The following instruments on XETRA do have their first trading 22.10.2025 Die folgenden Instrumente in XETRA haben ihren ersten Handelstag 22.10.2025
Aktien
1 KYG8827C1006 Malibu Life Holdings... ► Artikel lesen | |
| ASTRIA THERAPEUTICS | 12,870 | -0,39 % | BioCryst Pharmaceuticals, Inc.: BioCryst to Acquire Astria Therapeutics, Strengthening Presence in HAE, Transforming Growth Profile | - Deal to add navenibart, a late-stage and long-acting plasma kallikrein inhibitor, in Phase 3 clinical development, to BioCryst's HAE portfolio - - Solidifies double digit growth trajectory for HAE... ► Artikel lesen | |
| SANTHERA PHARMACEUTICALS | 13,200 | -1,05 % | Santhera Pharmaceuticals Holding AG: Santhera Closes USD 13 Million Royalty Monetization Agreement | Pratteln, Switzerland, November 5, 2025 - Santhera Pharmaceuticals (SIX: SANN) announces the closing of a USD 13 million royalty monetization agreement, first announced in September 2025, to support... ► Artikel lesen | |
| TONIX PHARMACEUTICALS | 15,800 | -0,63 % | Tonix Pharmaceuticals Holding Corp.: Tonix Pharmaceuticals Announces Licensing TNX-4900, a Selective Sigma-1 Receptor Antagonist for Chronic Neuropathic Pain from Rutgers University | Non-opioid analgesic shows efficacy in several animal pain models, including diabetic and chemotherapy-induced neuropathic pain Compelling safety and pharmacokinetic profiles in animals support IND-enabling... ► Artikel lesen |